• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSS1300003 甲氧聚二醇重组人促红素注射液 Injection Biological Products Import Drug Application 2013-06-18 Roche Diagnostics GmbH;Roche Pharma (Schweiz) Ltd Certificate Issued 2014-06-10 view
JXSL1000030 甲氧聚二醇重组人促红素注射液 Injection Biological Products Import Drug Application 2010-08-04 Roche Pharma (Schweiz) Ltd Certificate Issued 2013-02-19 view
JYSB2200153 甲氧聚二醇重组人促红素注射液 Injection Biological Products Supplementary Application 2022-08-12 F Hoffmann-La Roche AG;Roche Pharma (Schweiz) AG view
JYSZ2200042 甲氧聚二醇重组人促红素注射液 Injection Biological Products License Renew 2022-08-30 Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG;Roche (China) Holding Ltd view
J0401452 重组人红细胞生成素-beta 注射液 Injection Biological Products Supplementary Application 2004-08-12 Shanghai Roche Pharmaceuticals Ltd Beijing Certificate Issued 2005-05-09 view
CYSB2400203 人促红素注射液 Human Erythropoietin Injection Biological Products Supplementary Application 2024-08-08 NCPC Genetech BIOTECHNOLOGY Co Ltd view
CYSB2101254 人促红素注射液 Human Erythropoietin Injection Biological Products Supplementary Application 2021-11-04 NCPC Genetech BIOTECHNOLOGY Co Ltd view
CYSB2200264 人促红素注射液 Human Erythropoietin Injection Biological Products Supplementary Application 2022-11-22 Shenyang Sunshine Pharmaceutical Co Ltd view
CYSB2200100 人促红素注射液 Human Erythropoietin Injection Biological Products Supplementary Application 2022-03-30 Kexing Biopharm Co Ltd view
JYSB2101070 重组人促红素-β注射液(CHO细胞) Recombinant Human Erythropoietin β(CHO Cell) Injection Biological Products Supplementary Application 2021-06-30 Roche Diagnostics GmbH;Roche Pharma (Schweiz) Ltd view
CYSB2400064 人促红素注射液 Human Erythropoietin Injection Biological Products Supplementary Application 2024-03-09 Shenyang Sunshine Pharmaceutical Co Ltd;Nmv Desen Biotech Co Ltd view
CYSB2101009 重组人促红素注射液(CHO细胞) Human Erythropoietin Injection Biological Products Supplementary Application 2021-03-22 Beijing Four Rings Bio-Pharmaceutical Co Ltd view
JYSB2300071 甲氧聚二醇重组人促红素注射液 Injection Biological Products Supplementary Application 2023-04-26 Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG view
JXSL1000034 甲氧聚二醇重组人促红素注射液 Injection Biological Products Import Drug Application 2010-08-04 Roche Pharma (Schweiz) Ltd Certificate Issued 2013-02-19 view
JYSB2200127 人促红素注射液 Human Erythropoietin Injection Biological Products Supplementary Application 2022-07-14 Nichi-Iko Gifu Plant Co Ltd;Kyowa Hakko Kirin Co Ltd view
JYSB2101197 重组人促红素-β注射液(CHO细胞) Recombinant Human Erythropoietin β(CHO Cell) Injection Biological Products Supplementary Application 2021-12-17 Roche Diagnostics GmbH;Roche Pharma (Schweiz) Ltd view
CYSB2400178 人促红素注射液 Human Erythropoietin Injection Biological Products Supplementary Application 2024-07-09 Shenyang Sunshine Pharmaceutical Co Ltd view
JYSZ0800024 注射用重组人红细胞生成素 Recombinant Human Erythropoietin(CHO Cell) Lyophilized Biological Products License Renew 2008-02-22 Biosidus SA Certificate Issued 2019-03-21 view
CYSB2200215 人促红素注射液 Human Erythropoietin Injection Biological Products Supplementary Application 2022-08-26 Shenyang Sunshine Pharmaceutical Co Ltd view
JXSS1300007 甲氧聚二醇重组人促红素注射液 Injection Biological Products Import Drug Application 2013-06-18 Roche Diagnostics GmbH;Roche Pharma (Schweiz) Ltd Certificate Issued 2018-05-24 view